MUC5AC and colorectal carcinoma: To determine the role of secretory mucin MUC5AC in CRC chemoresistance, we used 5-FU, which is mostly used for CRC therapy along with oxaliplatin (an alkylating agent widely used for treating advanced CRC in combination with 5-FU).